| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |